Cargando…

Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination

Detalles Bibliográficos
Autores principales: Valsecchi, Carla, Gualtierotti, Roberta, Arcudi, Sara, Ciavarella, Alessandro, Schiavone, Lucia, Novembrino, Cristina, Siboni, Simona Maria, Mannucci, Pier Mannuccio, Peyvandi, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665216/
http://dx.doi.org/10.1182/blood-2022-162183
_version_ 1784831241622650880
author Valsecchi, Carla
Gualtierotti, Roberta
Arcudi, Sara
Ciavarella, Alessandro
Schiavone, Lucia
Novembrino, Cristina
Siboni, Simona Maria
Mannucci, Pier Mannuccio
Peyvandi, Flora
author_facet Valsecchi, Carla
Gualtierotti, Roberta
Arcudi, Sara
Ciavarella, Alessandro
Schiavone, Lucia
Novembrino, Cristina
Siboni, Simona Maria
Mannucci, Pier Mannuccio
Peyvandi, Flora
author_sort Valsecchi, Carla
collection PubMed
description
format Online
Article
Text
id pubmed-9665216
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The American Society of Hematology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-96652162022-11-16 Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination Valsecchi, Carla Gualtierotti, Roberta Arcudi, Sara Ciavarella, Alessandro Schiavone, Lucia Novembrino, Cristina Siboni, Simona Maria Mannucci, Pier Mannuccio Peyvandi, Flora Blood Online Publication Only The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665216/ http://dx.doi.org/10.1182/blood-2022-162183 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Online Publication Only
Valsecchi, Carla
Gualtierotti, Roberta
Arcudi, Sara
Ciavarella, Alessandro
Schiavone, Lucia
Novembrino, Cristina
Siboni, Simona Maria
Mannucci, Pier Mannuccio
Peyvandi, Flora
Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
title Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
title_full Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
title_fullStr Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
title_full_unstemmed Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
title_short Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination
title_sort markedly reduced fviii recovery associated with anti-fviii peg antibodies after bnt162b2 sars-cov-2 vaccination
topic Online Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665216/
http://dx.doi.org/10.1182/blood-2022-162183
work_keys_str_mv AT valsecchicarla markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT gualtierottiroberta markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT arcudisara markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT ciavarellaalessandro markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT schiavonelucia markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT novembrinocristina markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT sibonisimonamaria markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT mannuccipiermannuccio markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination
AT peyvandiflora markedlyreducedfviiirecoveryassociatedwithantifviiipegantibodiesafterbnt162b2sarscov2vaccination